Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
26.2 GBX | -5.07% | +3.97% | +3.97% |
Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Feb. 29 | Oncimmune Holdings plc Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Business Summary
Number of employees: 52
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
ImmunoINSIGHTS
100.0
%
| 2 | 60.8 % | 1 | 100.0 % | -37.47% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
93.1
%
| 1 | 21.4 % | 1 | 93.1 % | +65.64% |
Europe
6.9
%
| 1 | 19.8 % | 0 | 6.9 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 23-07-31 | |
Martin Hudson
DFI | Director of Finance/CFO | - | 23-09-03 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Tariq Sethi
CTO | Chief Tech/Sci/R&D Officer | - | 19-09-30 |
Ron Kirschner
COO | Chief Operating Officer | - | 20-04-19 |
Cléa Rosenfeld
IRC | Investor Relations Contact | - | 19-06-30 |
Matthew Luttrell
PRN | Corporate Officer/Principal | - | 19-09-30 |
Cameron Barnard
PRN | Corporate Officer/Principal | - | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Goold
BRD | Director/Board Member | 52 | 23-01-12 |
Timothy Bunting
BRD | Director/Board Member | 61 | 15-10-08 |
Ron Kirschner
COO | Chief Operating Officer | - | 20-04-19 |
Chief Executive Officer | 57 | 23-07-31 | |
Director/Board Member | - | 23-10-11 | |
Chairman | 54 | 22-07-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,142,147 | 52,785,507 ( 71.20 %) | 0 | 71.20 % |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.97% | 23.95M | |
+2.50% | 68.35B | |
-16.14% | 4.78B | |
+4.07% | 3.87B | |
+19.02% | 3.73B | |
+27.09% | 2.52B | |
-27.48% | 2.27B | |
-25.70% | 2.21B | |
+7.46% | 1.95B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ONC Stock
- Company Oncimmune Holdings plc